We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Energy and Commerce Committee Seeks Details on FDA’s Stem Cell Enforcement
Energy and Commerce Committee Seeks Details on FDA’s Stem Cell Enforcement
The clock is ticking on the FDA’s enforcement discretion period for stem cells and other new therapies, and Congress raised concerns and questions with the agency about its plans going forward in a letter last week.